<strong>Background:</strong> <span><span><span style="font-family:""><span style="font-family:Verdana;">Acute kidney injury (AKI) is a life threatening cond...<strong>Background:</strong> <span><span><span style="font-family:""><span style="font-family:Verdana;">Acute kidney injury (AKI) is a life threatening condition with still high mortality rate in neonates. Early recognition of the risk factors and the rapid effective treatment of the contributing conditions will reduce AKI in the neonatal period. </span><b><span style="font-family:Verdana;">Aim of the Work: </span></b><span style="font-family:Verdana;">To determine association between early caffeine citrate administration and risk of acute kidney injury in hospitalized preterm neonates.</span> <b><span style="font-family:Verdana;">Patients and Methods</span></b><b><span style="font-family:Verdana;">: </span></b><span style="font-family:Verdana;">This study was a prospective study that was conducted at the NICU of El Galaa Teaching Hospital. This study included 100 preterm neonates who </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">were </span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;">born alive from 32 weeks to 35 weeks of gestation. </span><b><span style="font-family:Verdana;">Results: </span></b><span style="font-family:Verdana;">There was highly statistically significant occurrence of apneaic episode in preterm babies who don</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">’</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">t receive caffeine citrate and consequently decreased incidence of AKI in those babies</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">. </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">Conclusion: </span></b></span></span><span style="font-family展开更多
文摘<strong>Background:</strong> <span><span><span style="font-family:""><span style="font-family:Verdana;">Acute kidney injury (AKI) is a life threatening condition with still high mortality rate in neonates. Early recognition of the risk factors and the rapid effective treatment of the contributing conditions will reduce AKI in the neonatal period. </span><b><span style="font-family:Verdana;">Aim of the Work: </span></b><span style="font-family:Verdana;">To determine association between early caffeine citrate administration and risk of acute kidney injury in hospitalized preterm neonates.</span> <b><span style="font-family:Verdana;">Patients and Methods</span></b><b><span style="font-family:Verdana;">: </span></b><span style="font-family:Verdana;">This study was a prospective study that was conducted at the NICU of El Galaa Teaching Hospital. This study included 100 preterm neonates who </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">were </span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;">born alive from 32 weeks to 35 weeks of gestation. </span><b><span style="font-family:Verdana;">Results: </span></b><span style="font-family:Verdana;">There was highly statistically significant occurrence of apneaic episode in preterm babies who don</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">’</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">t receive caffeine citrate and consequently decreased incidence of AKI in those babies</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">. </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">Conclusion: </span></b></span></span><span style="font-family
